A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
Clinical trial NCT05217082 · COMPLETED
Trial details
- NCT number
- NCT05217082
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-22
- Primary completion
- 2022-08-03
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.